Does maternal obesity cause preeclampsia? A systematic review of the evidence

Minerva Ginecologica

Volumn 64, Issue 4, 2012, Pages 259-280

  Salihu, H M ^a,b   De La Cruz, C ^b   Rahman, S ^b   August, E M ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Hypertension, pregnancy induced; Obesity; Preeclampsia; Pregnancy

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; LEPTIN; SEX HORMONE BINDING GLOBULIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANTIHYPERTENSIVE THERAPY; BODY MASS; DISEASE ASSOCIATION; HUMAN; MATERNAL OBESITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PROTEIN BLOOD LEVEL; PROTEINURIA; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; OBESITY; PRE-ECLAMPSIA; PREGNANCY;

EID: 84867309881     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva, Switzerland: World Health Organization; 2011.
2. Williams PJ, Broughton Pipkin F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:405-17.
3. Harskamp RE, Zeeman GG. Preeclampsia: At risk for remote cardiovascular disease. Am J Med Sci 2007;334:291-5. (Pubitemid 351339288)
4. Mignini LE, Villar J, Khan KS. Mapping the theories of preeclampsia: The need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 2006;194:317-21. (Pubitemid 43183678)
5. World Health Organization. Detecting preeclampsia: A practical guide, using and maintaining blood pressure equipments. Geneva, Switzerland: World Health Organization; 2005.
6. WHO Study Group. The hypertensive disorders of pregnancy. Geneva, Switzerland: World Health Organization; 1987.
7. Dolea C, AbouZhar C. Global burden of hypertensive disorders of pregnancy in the year 2000. Geneva, Switzerland: World Health Organization; 2003.
8. Redman CW, Sargent IL. Latest Advances in Understanding Preeclampsia. Science 2005;308:1592-4. (Pubitemid 40807500)
9. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
10. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci(Lond) 2006;111:81-6. (Pubitemid 44023414)
11. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998;147:1062-70.
12. Parazzini F, Bortolus R, Chatenoud L, Restelli S, Ricci E, Marozio L et al. Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. Epidemiology 1996;7:306-8. (Pubitemid 26120380)
13. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008;21:521-6. (Pubitemid 351589674)
14. Centers for Disease Prevention and Control. Obesity and overweight. Atlanta, GA: Centers for Disease Prevention and Control; 2010.
15. El-Gilany A-H, Hammad S. Body mass index and obstetric outcomes in Saudi Arabia: a prospective cohort study. Ann Saudi Med 2010;30:376-80.
16. Gaillard R, Steegers EAP, Hofman A, Jaddoe VWV. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens 2011;29.937-44.
17. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 2007;18:365-70. (Pubitemid 350137763)
18. Bo S, Menato G, Signorile A, Bardelli C, Lezo A, Gallo ML et al. Obesity or diabetes: what is worse for the mother and for the baby? Diabetes Metabolism 2003;29:175-8. (Pubitemid 36576098)
19. Nohr EA, Timpson NJ, Andersen CS, Davey Smith G, Olsen J, Sorensen TI. Severe obesity in young women and reproductive health: the Danish National Birth Cohort. PLoS One 2009;4.e8444.
20. Burstein E, Levy A, Mazor M, Wiznitzer A, Sheiner E. Pregnancy Outcome among obese women: a prospective study. Am J Perinatology 2008;25:561-6.
21. Mahomed K, Williams MA, Woelk GB, Jenkins-Woelk L, Mudzamiri S, Longstaff L et al. Risk factors for preeclampsia among Zimbabwean women: maternal arm circumference and other anthropometric measures of obesity. Paediatr Perinat Epidemiol 1998;12:253-62. (Pubitemid 28365250)
22. Spinillo A, Capuzzo E, Baltaro F, Piazzi G, Iasci A. Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 1995;9:623-5.
23. Srinivas SK, Sammel MD, Bastek J, Ofori E, Andrela CM, Wolfe ML et al. Evaluating the association between all components of the metabolic syndrome and pre-eclampsia. Journal of Maternal-Fetal & Neonatal Medicine 2009;22:501-9.
24. Briese V, Voigt M, Hermanussen M, Wittwer-Backofen U. Morbid obesity: Pregnancy risks, birth risks and status of the newborn. Homo-Journal of Comparative Human Biology 2010;61:64-72.
25. Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 2009;200:395 e1-9.
26. Colatrella A, Braucci S, Festa C, Bianchi P, Fallucca F, Mattei L, et al. Hypertensive Disorders in Normal/Over-weight and Obese Type 2 Diabetic Pregnant Women. Experiment Clin Endocrinol Diabetes 2009;117:373-7.
27. Barden AE, Beilin LJ, Ritchie L, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertension 1999;17:1307-15. (Pubitemid 29509510)
28. Fox NS, Saltzman DH, Kurtz H, Rebarber A. Excessive weight gain in term twin pregnancies examining the 2009 institute of medicine definitions. Obstet Gynecol 2011;118:1000-4.
29. Joy S, Istwan N, Rhea D, Desch C, Stanziano G. The Impact of maternal obesity on the incidence of adverse pregnancy outcomes in high-risk term pregnancies. Am J Perinatology 2009;26:345-9.
30. Briese V, Voigt M, Wisser J, Borchardt U, Straube S. Risks of pregnancy and birth in obese primiparous women: an analysis of German perinatal statistics. Arch Gynecol Obstet 2011;283:249-53.
31. Diouf I, Charles MA, Thiebaugeorges O, Forhan A, Kaminski M, Heude B. Maternal weight change before pregnancy in relation to birthweight and risks of adverse pregnancy outcomes. Eur J Epidemiology 2011;26:789-96.
32. Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT*study. Qjm-Monthly J Association of Physicians 2001;94:347-56. (Pubitemid 32655203)
33. Hendler I, Schat M, Momirova V, Wise R, Landon M, Mabie W et al. Association of obesity with pulmonary and nonpulmonary complications of pregnancy in asthmatic women. Obstet Gynecol 2006;108:77-82. (Pubitemid 44336848)
34. Saeed F, Jawad A, Azmat A, Azam I, Kagazwala S. Anthropometric measurements as a risk for hypertensive disorders in pregnancy: A hospital based study in South Asian population. J Pakistan Med Association 2011;61:58-63.
35. Bienertova-Vasku J, Dostalova Z, Kankova K, Bienert P, Vasku A, Unzeitig V. Is there any link between severe pre-eclampsia and defined polymorphisms in leptin and adiponectin genes? J Obstet Gynaecol Res 2008;34.858-64.
36. Dalamaga M, Srinivas SK, Elovitz MA, Chamberland J, Mantzoros CS. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case-control study. Metabol Clin Experimental 2011;60:1539-44.
37. Palei AC, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clin Biochem 2008;41:875-80.
38. Scholl TO, Chen X, Goldberg GS, Khusial PR, Stein TP. Maternal diet, C-reactive protein, and the outcome of pregnancy. J Am Coll Nutr 2011;30:233-40.
39. Qiu CF, Luthy DA, Zhang CL, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertension 2004;17:154-60. (Pubitemid 38125133)
40. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: The potential role of inflammation. Obstet Gynecol 2001;98:757-62. (Pubitemid 33042541)
41. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: A prospective study. J Clin Endocrinol Metabolism 2002;87:1563-8. (Pubitemid 34615240)
42. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4. (Pubitemid 20007682)
43. Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod Sci 2007;14:629-45. (Pubitemid 351903568)
44. Merchant SJ, Davidge ST. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia. BJOG 2004;111:931-9. (Pubitemid 39223042)
45. Merchant SJ, Narumiya H, Zhang Y, Guilbert LJ, Davidge ST. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 2004;23:47-60. (Pubitemid 38445552)
46. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metabol 2003;88:2393-8. (Pubitemid 36724402)
47. Solomon CG, Seely EW. Brief Review: Hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001;37:232-9. (Pubitemid 32199080)
48. Hill AB. The Environment and Disease: Association or Causation? Proc R Soc Med 1965;58:295-300.